Skip to content

A prospective, randomized, intra-patient, comparative, open, multi-centre study to evaluate the efficacy of a Single-Use Negative Pressure Wound Therapy (NPWT) System (PICO) on the prevention of postsurgical incision healing complications in patients undergoing reduction mammoplasty

A prospective, randomized, intra-patient, comparative, open, multi-centre study to evaluate the efficacy of a Single-Use Negative Pressure Wound Therapy (NPWT) System (PICO) on the prevention of postsurgical incision healing complications in patients undergoing reduction mammoplasty - The effectivity of a negative pressure system (PICO)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36873
Enrollment
30
Registered
2012-08-20
Start date
2012-10-09
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bilaterale mammoplasty

Interventions

PICO is a Single-Use Negative Pressure Wound Therapy (NPWT) System consisting of a small portable pump, 2 lithium batteries, 2 dressings and 10 fixation strips. PICO is capable of delivering 80mmHg

Sponsors

Smith&Nephew, Inc
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Pre-surgery 1 * Female patient*s *18 years old 2 - The patient is able to understand the trial and is willing to consent to the trial Post-surgery;3 * Patient has undergone an elective surgical procedure for bilateral reduction mammoplasty;4 - Patients postsurgical incisions are of similar length

Exclusion criteria

Exclusion criteria: Pre-surgery Pregnant or lactating females 5 * Pregnant or lactating females;6 * Patients on steroids or other immune modulators known to impact healing which may affect scar appearance;7 * Patients with tattoos in the area of the incisions;8 * Patients with skin conditions (Cutis laxa etc.) that would result in poor healing or widened scars;9 * Patients with a known significant history of scar problems i.e. hypertrophic scaring or keloids;10 * Patients who in the opinion of the investigator may not complete the study for any reason;11 * Patients with a known history of poor compliance with medical treatment;12 * Patients who have participated in this trial previously and who were withdrawn;13 * Patients with known allergies to product components (silicone adhesives and polyurethane films (direct contact with wound), acrylic adhesives (direct contact with skin), polyethylene fabrics and super-absorbent powders (polyacrylates) (within the dressing);Post-surgery;14 - Incisions that are actively bleeding;15 - Exposure of blood vessels, organs, bone or tendon at the base of the reference wound;16 - Incisions >12 inches (30cm) max linear dimension

Design outcomes

Primary

MeasureTime frame
To assess the difference in healing complications up to and 21 days post-operatively between postsurgical incisions treated with PICO compared with standard of care

Secondary

MeasureTime frame
To assess the aesthetic appearance and scar quality using POSAS-, VAS Questionnaires and the hydratation, elasticity and the Transepidermal Water Loss of the scar using the cutometer , the aspects of functional performance of both dressings, the ease of operation of the PICO pump, any changes in the surrounding skin condition and the assessment of a difference in the following economic assessments

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)